Personalis Lands $50M Merck Investment, Extends Key Moderna Partnership for Cancer Therapy Platform
Personalis (NASDAQ: PSNL) announced two significant agreements: a $50 million investment from Merck through private...
Personalis (NASDAQ: PSNL) announced two significant agreements: a $50 million investment from Merck through private...